Previous Article | Next Article 
Journal of Virology, October 1999, p. 8290-8302, Vol. 73, No. 10
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
trans-Dominant Interference with Human
Immunodeficiency Virus Type 1 Replication and Transmission in
CD4+ Cells by an Envelope Double Mutant
Steve S.-L.
Chen,*
Sheau-Fen
Lee,
Chin-Kai
Chuang,
and
V. Samuel
Raj
Division of Infectious Diseases, Institute of
Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China
Received 8 March 1999/Accepted 2 July 1999
 |
ABSTRACT |
We previously reported that a human immunodeficiency virus type 1 (HIV-1) envelope (Env) mutant with the whole cytoplasmic domain
deleted, denoted mutant TC, is able to dominantly interfere with
wild-type (wt) virus infectivity. In the present study, the feasibility
of developing a dominant negative mutant-based genetic anti-HIV
strategy targeting the gp41 cytoplasmic domain was investigated. Mutants TC and 427,TC, a TC derivative with a Trp-to-Ser substitution introduced into residue 427 in the CD4-binding site, and a series of
mutants with deletions in the cytoplasmic domain, effectively trans-dominantly interfered with wt Env-mediated viral
infectivity, as demonstrated by an env
trans-complementation assay. The syncytium formation-defective
427,TC double mutant not only inhibited heterologous LAV and ELI
Env-mediated viral infectivity but also interfered with syncytium
formation and infectivity mediated by the Env proteins of the two
primary isolates 92BR and 92US. Stable HeLa-CD4-LTR-
-gal clones that
harbored Tat-controlled expression cassettes encoding the control
KS, which had a deletion in the env gene, wt, or mutant
env gene were generated. Viral transmission mediated by laboratory-adapted T-cell-tropic HXB2 and NL4-3 viruses was greatly reduced in the TC and 427,TC transfectants compared to that observed in
the control
KS and wt transfectants. Viral replication caused by
HXB2 and NL4-3 viruses and by macrophage-tropic ConB and ADA-GG viruses
was delayed or reduced in human CD4+ T cells transfected
with the 427,TC env construct compared to that observed in
cells transfected with the control
KS or TC env
construct. The lack of significant interference by TC mutant was due
neither to the lack of TC env gene integration into host DNA nor to the lack of TC Env expression upon Tat induction. These results indicate that this 427,TC Env double mutant has a role in the
development of trans-dominant mutant-based genetic anti-HIV strategies.
 |
INTRODUCTION |
The transmembrane (TM) protein gp41
cytoplasmic domain of human immunodeficiency virus type 1 (HIV-1) spans
residues 706 to 856 of the envelope (Env) protein. Mutations or
deletions in the cytoplasmic domain affect various steps of the virus
life cycle, such as virus replication, viral infection and
transmission, cytopathogenicity, Env stability, and Env incorporation
into virions (9, 16, 17, 19, 24, 27, 28, 30, 34, 41, 46). In
addition, this domain has been implicated in interaction with matrix
(MA) protein during virus assembly and budding (15, 22, 23, 33, 45). This notion has been further supported by the demonstration of direct in vitro protein binding between the gp41 cytoplasmic domain
and MA (14). It was shown that the cytoplasmic domain contains a membrane-proximal tyrosine-based, basolateral targeting signal for virus budding in polarized cells (31). The same
tyrosine residue was also implicated in the high rate of
internalization by endocytosis of endogenously synthesized Env protein
from the plasma membrane (37). Moreover, peptide homologues
mimicking lentivirus lytic peptide (LLP)-1 and LLP-2 were found to
display cytolytic and calmodulin-binding and -inhibitory properties
(38, 40). Because of its multifunctional role in various
stages of the virus replication cycle and its involvement in
cellular dysfunction and cytopathogenesis, the cytoplasmic domain
of gp41 may represent an ideal target for the design of an anti-HIV strategy.
In this regard, we previously characterized an HIV-1 proviral DNA clone
HXV-m and found that the Env encoded by this clone is truncated in the
cytoplasmic domain (9). We also demonstrated that this
mutant dominantly interferes with the infectivity of the HXB2 virus
when the HXB2 and HXV-m proviruses are coexpressed. This
trans-dominant defect in infectivity by the HXV-m mutant Env
may be attributed to the formation of a dysfunctional complex between
the wild-type (wt) and mutant Env proteins when they are coexpressed
(9). Our studies suggest that a trans-dominant negative mutant-based anti-HIV strategy can be designed to target the
gp41 cytoplasmic domain.
Alterations to other functional domains in the Env protein may affect
the interference with wt viral infectivity by a dominant negative
mutant. An NL4-3 virus-derived Env mutant 41.2 with a polar Glu or Arg
substitution for the Val located at amino acid 2 of the membrane fusion
domain was demonstrated to be membrane fusion defective and to exhibit
a dominant interference effect with the wt viral infectivity (5,
21). Interestingly, a 12-amino-acid deletion in the CD4-binding
domain greatly reduces the interference by mutant 41.2 (5).
That study indicates that a functional CD4-binding region is required
for the dominant interference of the 41.2 mutant. Likewise, an
understanding of whether the dominant interference by the cytoplasmic
domain truncation mutant requires CD4-binding ability should provide
insight into what sequences in the CD4-binding domain are necessary for
this dominant interference.
A consideration of a genetic anti-HIV therapeutic design is to target
the genes with an intervention or therapeutic purpose to human
CD4+ or other HIV-susceptible cells so that the conference
of an anti-HIV state to the host cells by the target gene products can
be assessed. The issue of whether previously reported Env-based
dominant mutants (4, 9, 11, 21, 39) could interfere with
viral replication and spread in human CD4+ T cells, which
are natural host cells for HIV infection, has never been documented.
Primary or macrophage (M)-tropic isolates of HIV-1 play an important
role in HIV pathogenesis throughout the lifetime of infected individuals. The prototypic subtype B strain HXB2 and primary isolates
display considerable differences in their genetic, phylogenetic, and
biological characteristics (25). The amino acid sequences of
the env genes between members of each subtype typically vary from 3 to 23%. Utilizing trans-dominant mutants in the
design of an anti-HIV approach requires that the gene products of
dominant negative mutants exhibit broad cross-interference with
infections caused by different viral isolates. The fusion-defective
mutant 41.2 was shown to interfere in trans with syncytium formation caused by the Env of a heterologous WMJ-2 strain (21) and to inhibit viral transmission in HeLa-CD4 stable clones (4).
Whether this mutant and other Env-based dominant negative mutants
(4, 5, 9, 11, 21, 39) could interfere with the viral
replication and spread of heterologous laboratory-adapted T-cell
(T)-tropic and M-tropic viruses has not yet been addressed. In
addition, whether env-targeted dominant negative mutants
could be utilized in the design of genetic anti-HIV strategies to
combat HIV infection is not known.
In the present study, we attempted to explore the feasibility of
developing a cytoplasmic domain-based genetic anti-HIV approach. Interference with viral infectivity by an HXB2 strain-isogenic, cytoplasmic domain-truncated Env mutant (TC mutant) and its derivative, in which the CD4-binding ability of the TC Env mutant was abrogated (427,TC mutant), and by Env mutants with a series of deletions from the
C terminus of the cytoplasmic tail was investigated. Both TC and 427,TC
mutants confer interference with viral infection when these
Tat-inducible mutant env gene constructs are stably transferred into CD4+ HeLa derivatives. However, viral
replication is interfered with only in human CD4+ T
cells harboring the 427,TC env gene, not in cells harboring the TC env gene. These results indicate that a functional
CD4-binding domain is not required for interference by the TC
mutant. Our study also provides the first demonstration of Env-based
dominant interference with replication and spread caused by T-tropic
and M-tropic viruses in targeted human CD4+ T cells.
 |
MATERIALS AND METHODS |
Cells and plasmids.
HeLa-CD4-LTR-
-gal, SupT1, COS-1, 293 cells, and hybridoma Chessie 8 were all previously described
(11). pGEM-EB, pBaby, pBSX, pSVE7, pSVE7(
KS),
pIIIextat, HXB2gpt, and pHXBCAT
Bgl were all
previously described (8-11).
Construction of plasmids.
A method that selects against a
single-stranded DNA template containing uracil (29) was
followed to construct env mutants (Fig. 1). Briefly, the
uracil-containing single-stranded DNA template of pGEM-EB
(10) was primed with the synthetic oligonucleotide 5'
GCTTGGTAGGTTTAAGAATATTTTTGCTGTACTTTCTATAG 3' (nucleotides 8295 to
8336 with a deletion of G at position 8315 of the HXB2 sequence) to
prepare the replicative form of the pGEM-EB(TC) (Fig. 1A). Oligonucleotide 5'
AAACAAATTATAAACATGTCGCAGAAAGTAGGAAAAGCA 3' (nucleotides positioned from 7484 to 7522; the codon underlined encodes a Trp-to-Ser substitution at residue 427 in the CD4-binding site) was used to prime the uracil-containing single-stranded template
of pGEM-EB(TC) to produce pGEM-EB(427,TC). The
KpnI-BamHI fragments isolated from pGEM-EB(TC)
and pGEM-EB(427,TC) were then substituted for the corresponding
sequences in pBSX and pSVE7 to generate pBSX- and pSVE7-based mutant
env-expressing vectors, respectively. pSVE7-puro
(Fig. 1B), which encodes a bacterial puromycin resistance gene
(puro), was constructed as follows. The 440 bp of the
EcoRI fragment, which contains a simian virus 40 (SV40)
ori and is located outside of the coding sequences of HIV-1
long terminal repeat (LTR) and env in pSVE7, was deleted by
EcoRI digestion. The isolated vector was treated with calf intestine alkaline phosphatase, followed by filling-in with Klenow enzyme to generate a blunt-ended fragment. The puromycin resistance expression cassette, containing the SV40 early promoter,
puro, and an SV40 polyadenylation signal, was excised from
the pPUR vector (Clontech, Palo Alto, Calif.) by successive digestion
with BamHI, mung bean nuclease, and PvuII. The
isolated 1.4-kb DNA fragment was ligated to the treated 7.4-kb fragment
of the pSVE7 vector, resulting in pSVE7-puro. The
KpnI-BamHI sequence in the pSVE7-puro
was then replaced by the corresponding DNA fragments isolated from the
KS and mutant pSVE7 plasmids, yielding
KS and mutant
pSVE7-puro plasmids (Fig. 1B). pSVE7(
KS) is an
env-defective pSVE7 with a deletion from the KpnI
site to the StuI site. For construction of
pSVE7-puro plasmids that encoded a series of Env mutants
with deletions from the C terminus of the cytoplasmic tail (Fig. 3A),
the XhoI site located at the 5'-LTR of pSVE7-puro was destroyed by limited digestion. The KpnI-XhoI
sequence in this altered form of pSVE7-puro was then
replaced by the homologous sequences isolated from the HXB2R3 provirus
(45)-derived molecular clones TM709, TM752, TM775, TM795,
TM813, and TM844 (46). For construction of a Tat-controlled
LAV strain-derived env expression vector, the
KpnI fragment of the env gene in pSVIII-92RW
(25) was replaced by the 2.7-kb KpnI fragment
(nucleotides 6343 to 9005) isolated from pNL4-3 chimera (2).
DNA sequencing.
All mutant phagemids and constructs were
screened or confirmed by dideoxy-chain termination with Sequenase
(Amersham, Arlington Heights, Ill.). Primers 5' CCTCAGGAGGGGACCCAG
3' (nucleotides 7314 to 7331) and 5' TCCTCCAAGTCTGAAGATCTCG
3' (nucleotides 7639 to 7618) were used for forward and reverse
DNA sequencing, respectively, of the mutation in the CD4-binding site.
Primer 5' CACACGACCTGGATGGAG 3' (nucleotides 8096 to 8113)
was used to sequence the coding region encompassing the TC mutation.
Primer 688f (5' AGTAGGAGGCTTGGTAGG 3'; nucleotides 8287 to
8304), primer 734f (5' GAAGAAGAAGGTGGAGAGAGA 3'; nucleotides
8423 to 8445), and primer 793f (5' CTCAAATATTGGTGGAATCT 3';
nucleotides from 8600 to 8619) were used to sequence the TM series of pSVE7-puro plasmids.
Plasmid DNA transfection.
For COS-1 transfection, the
DEAE-dextran method as previously described was followed
(10). 293 cells were cotransfected with pHXBCAT
Bgl and
functional env plasmids in the presence or absence of mutant
env plasmids by the calcium phosphate coprecipitation method
(9, 11). The control pSVE7(
KS) plasmid, which does not
encode a functional env gene, was added into the
transfection mixtures to keep the amounts of DNA in all transfections
constant. Therefore, viruses obtained from cotransfection of
pHXBCAT
Bgl with pSVE7(
KS) were used as a negative control in all
env trans-complementation assays. For plasmid transfection
of HeLa-CD4-LTR-
-gal env transfectants, the calcium
phosphate coprecipitation method was employed. For DNA transfection of
P4-R5-MAGI, the Superfect transfection method (Qiagen, Valenica,
Calif.) was followed. For DNA transfection of SupT1 or
env-transfected CEM-SS cells, the DEAE-dextran transfection method was used.
Establishment of stably env-transfected cells.
The env pSVE7-puro plasmids were used to
transfect HeLa-CD4-LTR-
-gal cells by using the enhanced calcium
phosphate coprecipitation method (3). The transfected cells
were grown in medium containing puromycin, cloned, and expanded as
previously described (3). The single clones were screened
and confirmed by Southern hybridization and Western blotting. CEM-SS
and PM1 (107 cells) were transfected with 40 µg each of
pSVE7-puro constructs by electroporation by using an Electro
Cell Manipulator 600 (BTX Inc., San Diego, Calif.) at 250 V and 950 µF. Transfected cells were grown in medium supplied with 0.5 µg of
puromycin/ml for 3 weeks prior to viral infection studies.
Immunofluorescence microscopy.
pIIIextat-transfected HeLa-CD4-LTR-
-gal env
clones grown in 4-well, gelatinized slides were fixed with
phosphate-buffered saline (PBS) containing 4% paraformaldehyde on ice
for 1 h and permeabilized with 1% Triton X-100 in TBS (20 mM
Tris-HCl [pH 7.4] containing 137 mM NaCl) for 5 min. After blocking,
the slides were successively incubated with a 1:200 dilution of mouse
ascitic fluids obtained from hybridoma Chessie 13 and Chessie 8 and
with a 1:100 dilution of fluorescin isothiocyanate (FITC)-conjugated anti-mouse immunoglobulin (IgG) (Zymad Laboratories Inc., South San
Francisco, Calif.). After being washed, the slides were analyzed under
an Axiovert 135 fluorescence microscope (Zeiss, Jena, Germany).
Viral transmission and syncytium formation assays.
env-transfected COS-1 cells grown in 60-mm-diameter dishes
were cocultured with SupT1 cells as previously described (9) to determine syncytium formation. For the env
trans-complementation assay, recombinant viruses pseudotyped with
T-tropic or M-tropic Env proteins and containing the amounts of reverse
transcriptase (RT) activity as indicated in each experiment were used
to challenge HeLa-CD4-LTR-
-gal or P4-R5 MAGI indicator cells,
respectively. When env HeLa-CD4-LTR-
-gal transfectants
were infected with viruses, viruses containing 5 × 105 to 5 × 106 cpm of RT activity were
used. When RT activity of proviral DNA-transfected SupT1 cultures
reached 105 to 106 cpm/ml, 106 of
PBS-washed SupT1 cells were cocultured with HeLa-CD4-LTR-
-gal env transfectants grown in 60-mm-diameter petri dishes.
Three days after infection or coculture, the cells were fixed with PBS containing 1% formaldehyde and 0.2% glutaraldehyde at room
temperature for 5 min. The fixed and washed cells were stained with
Accustain (Sigma, St. Louis, Mo.), which contains May-Grünwald
and Giemsa stains, and cultures were then scored for syncytium
formation. To assess the cytopathic effects caused by the Env proteins
derived from primary isolates, P4-R5 MAGI cells were cotransfected with pIIIextat and wt pSVE7-puro and scored for
syncytium formation 2 days after transfection. For infection of
puromycin-selected CEM-SS or PM1 cells, virus containing 2 × 104 cpm of RT activity was used for challenge.
Enzymatic assays.
RT activity for cell-free viruses obtained
from proviral DNA-transfected culture supernatants or for virus
obtained from supernatants of infected cultures was determined as
previously described (9, 11). Entry of the defective
reporter virus into target cells was measured by chloramphenicol
acetyltransferase (CAT) activity as previously described
(9).
PCR amplification.
PBS-washed, env-transfected
CEM-SS cells were lysed with 10 mM Tris-HCl (pH 8.0) containing 50 mM
KCl, 2.5 mM MgCl2, 0.1 mg of gelatin/ml, 0.45% Nonidet
P-40, and 0.45% Tween 20 at a cell density of 5 × 106 cells/ml. The cell lysates were incubated at 56°C for
2 h, followed by incubation at 95°C for 10 min. Primers 5'
AGCAGCAGGAAGCACTATGG 3' (sense) and 5' CCAGACTGTGAGTTGCAACAG
3' (antisense), corresponding to the nucleotide sequences 7795 to
7814 and 7936 to 7916, respectively, of the HXB2 sequence were used in
PCR to detect the env sequences in transfected CEM-SS cells.
PCR with a pair of oligonucleotides complementary to the first exon of
the human
-globin gene at nucleotides 14 to 33 (5'
ACACAACTGTGTTCACTAGC 3' [sense]) and nucleotides 123 to 104 (5' CAATTCATCCACGTTCACC 3' [antisense]), relative to the
translation initiation site was also performed to normalize the total
amount of cellular DNA present in samples. The PCR buffer compositions
were those recommended by Perkin-Elmer (Norwalk, Conn.). The samples
were subjected to 35 cycles of amplification at 94°C for 30 s,
55°C for 30 s, and 72°C for 60 s on a GeneAmp PCR system
2400 (Norwalk, Conn.).
 |
RESULTS |
Construction and characterization of cytoplasmic domain-truncated
Env mutants.
To explore the feasibility of developing a genetic
anti-HIV strategy targeting the gp41 cytoplasmic domain, an HXB2 strain (18, 36)-isogenic mutant TC clone was constructed by
site-directed mutagenesis. This TC mutant encoded an Env with a
premature termination of translation after leucine at position 703 in
the gp41 TM region (Fig.
1A).
To determine whether a functional CD4-binding domain was required for
dominant interference by mutant TC, the CD4-binding ability of this
mutant was abrogated. A single Ser substitution for the Trp located at
residue 432 of the HIV-1 BRU Env was shown to block the
receptor-binding ability of the Env and to render the virus carrying
this mutation unable to replicate in SupT1 and U937 cells
(13). Therefore, oligonucleotide-directed mutagenesis was
performed to alter the TC env gene to encode an additional Trp-to-Ser substitution at residue 427 in the CD4-binding site (Fig.
1B). The TC and 427,TC double mutant env genes were all subcloned into pBSX- and pSVE7-based Env expression vectors. Both pBSX(TC) and pBSX(427,TC) encoded gp120 and a truncated gp160 precursor (data not shown). To determine the syncytium-forming ability
of these mutants, wt or mutant pBSX-transfected COS-1 cells were
cocultured with SupT1 cells, and syncytium formation was observed under
a light microscope 18 h after coculture. Transfection with wt pBSX
or pBSX(TC) resulted in significant syncytium formation (more than 200 giant cells in a 6-well dish) (Fig. 1C, panels b and c, respectively).
Transfection with pBSX(427,TC) did not show any syncytia (Fig. 1C,
panel d), consistent with the phenotype of the 427,TC mutant in that
the Trp-to-Ser substitution in the CD4-binding site abolishes the
ability of Env to bind to CD4 (13).

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 1.
Construction and characterization of Env mutants.
(A) A schematic representation of the cytoplasmic domain truncation Env
mutant. Structural motifs in gp41 cytoplasmic domains are shown, such
as internalization signal YSPL and the tyrosine-based
basolateral-targeting signal located at residue 712, a highly
hydrophilic region, and two positively charged amphipathic -helices
marked LLP-1 and LLP-2. The amino acid residues are numbered according
to their positions in the Env of the HXB2 strain. The region
encompassing residues from 696 to 706 and its corresponding DNA
sequence are indicated. The deletion of the G base as underlined
located at nucleotide 8315 of the HXB2 sequence results in a frame
shift of the open reading frame and a premature termination of
translation after leucine at position 703 in the TM domain. (B)
Construction of wt and mutant pSVE7-puro plasmids. A
puromycin resistance expression cassette was inserted into the wt
pSVE7. The KpnI-BamHI fragments isolated from
various mutant pSVE7 plasmids were substituted for the corresponding
sequence in wt pSVE7-puro to generate various mutant
pSVE7-puro plasmids. The asterisk represents the stop codon
in the TM domain as described in panel A. Single-letter amino acid
codes are used. (C) Analysis of the syncytium-forming ability of Env
mutants. COS-1 cells were transfected with 2 µg each of pBaby, wt, or
mutant pBSX as indicated. Two days after transfection, 106
SupT1 cells were added into each transfected culture, and photographs
were taken 18 h after coculture under a light microscope.
Magnification, ×100.
|
|
Interference with wt Env-mediated viral infectivity by cytoplasmic
domain truncation mutants.
To determine whether TC and 427,TC
mutants interfered with wt Env-mediated viral infectivity, a
trans-complementation assay with an
env-defective, HIV-1 reporter provirus pHXBCAT
Bgl
(26) was performed. This assay measures the ability of Env
protein to mediate one round of viral replication. 293 cells were
cotransfected with pHXBCAT
Bgl along with the wt, TC, or 427,TC pSVE7
plasmid. Cotransfection with pHXBCAT
Bgl and pSVE7(
KS), with the
KpnI-StuI sequence deleted in the env
gene (Fig. 1B), was performed in parallel. Cell-free viruses containing
equal amounts of RT activity from each transfection were used to
challenge HeLa-CD4-LTR-
-gal cells, and cell lysates prepared 3 days
after infection were assayed for CAT activity. Env proteins encoded by
the 427,TC double mutant as well as by the TC mutant did not support
viral infectivity (Fig. 2A). Furthermore,
the 427,TC double mutant as well as the TC mutant significantly
interfered with wt Env-mediated viral infectivity when coexpressed with
the wt Env protein (Fig. 2B).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 2.
Assessment of mutant Env proteins by an env
trans-complementation assay. (A) Inability of mutant proteins to
mediate virus-to-cell transmission. 293 cells were cotransfected with
10 µg of pHXBCAT Bgl and 10 µg each of the control KS, wt, or
mutant pSVE7. Cell-free viruses containing 2 × 105
cpm of RT activity from each viral stock were used to challenge
HeLa-CD4-LTR- -gal cells, and CAT activity was measured. (B)
Interference with wt Env-mediated viral infectivity by Env mutants. 293 cells were cotransfected with 10 µg each of pHXBCAT Bgl and wt
pSVE7 in the presence or absence of 10 µg of mutant pSVE7 as
described in Materials and Methods. Viruses containing 2 × 105 cpm of RT activity from each transfection were used to
determine Env-mediated virus-to-cell transmission. In panels A and B,
the viruses used in the lanes marked control were produced from
cotransfection of pHXBCAT Bgl and pSVE7( KS). In panel B, the
pSVE7( KS) plasmid was added into transfection mixtures to maintain
the total DNA amounts in all transfection reactions at the same
levels.
|
|
Deletions in the cytoplasmic domain conferred dominant interference
with wt Env-mediated viral infectivity.
To determine whether
interference with viral infectivity was a general feature for deletions
in the cytoplasmic domain, interference with wt Env-induced viral
infectivity by a series of mutants with deletions from the C terminus
of the cytoplasmic domain was tested. The env genes encoded
by HXB2R3-derived proviral clones TM844, TM813, TM795, TM775, TM752,
and TM709 were subcloned into the pSVE7-puro vector (Fig.
3A). These env expression
plasmids encoded Env proteins with deletions after residues 844, 813, 795, 775, 752, and 709, respectively, to the C terminus of the
cytoplasmic domain. Viruses encoded by these TM proviruses typically
exhibit a phenotype of impaired infectivity (46). Migrations
of the Env precursors and TM subunits of these deletion mutants in
sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed a
ladder-like pattern (data not shown). Upon challenge to
HeLa-CD4-LTR-
-gal cells, viruses pseudotyped with wt and any of the
deletion mutants, even with deletions as small as 12 amino acids in the
C terminus (TM844), produced a much lower level of CAT than the virus
pseudotyped with the wt Env alone (Fig. 3B).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of coexpression with Env deletion mutants on wt
Env-mediated viral infectivity. (A) A schematic representation of a
series of Env mutants with deletions from the C terminus of the
cytoplasmic domain. The numbers in parentheses indicate that a stop
codon was introduced after the codon of the indicated residue. (B)
Interference with wt Env-mediated infectivity by deletion mutants. 293 cells were cotransfected with 7.5 µg of pHXBCAT Bgl and 7.5 µg of
wt pSVE7-puro in the presence or absence of 7.5 µg of
mutant pSVE7-puro plasmids that encoded deletion mutants as
indicated. Cell-free viruses containing 6.5 × 104 cpm
of RT activity from each viral supernatant were used to determine
Env-mediated virus-to-cell transmission to HeLa-CD4-LTR- -gal
cells.
|
|
Interference with functions mediated by heterologous T-tropic and
M-tropic Env proteins.
Viral infectivities mediated by the
defective virus pseudotyped with the Env of the LAV or ELI strain
(35), derived from two heterologous T-tropic isolates, and
by the defective virus pseudotyped with the LAV or ELI Env together
with the 427,TC Env mutant were compared. Coexpression with the 427,TC
mutant Env strikingly interfered with viral infectivity mediated by the
LAV or ELI Env protein (Fig. 4A).
Interference by this double mutant on syncytium formation mediated by
the 92BR and 92US Env proteins of two primary isolates (25)
was then examined. The P4-R5 MAGI indicator cell line, a HeLa
derivative which expresses CD4 and human CCR-5 and contains integrated
copies of the
-galactosidase gene fused to the HIV-1 LTR
(7), was cotransfected with pIIIextat along with
pSVIII-92BR or pSVIII-92US in the presence or absence of pSVE7(427,TC).
pIIIextat is an HIV-1 LTR-driven Tat expression plasmid.
Cells expressing the 92BR or 92US Env in the presence of 427,TC double
mutant in a 1:1 molar ratio of wt/427,TC plasmid showed a 25.3 and
30.8% reduction, respectively, in syncytium formation compared to
cells expressing the 92BR or 92US Env alone (Table
1). When the ratio of wt/427,TC plasmid
was set at 1:2, the reduction in syncytium formation was found to be
55.5 and 75.2%, respectively (Table 1). Moreover, defective virus
pseudotyped with 92BR or 92US Env in the presence of 427,TC mutant Env
significantly interfered with 92BR or 92US Env-mediated viral
infectivity (Fig. 4B).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Interference by the 427,TC double mutant with viral
infectivity. (A) Interference with viral infectivity mediated by
heterologous T-tropic Env proteins. 293 cells were cotransfected with
7.5 µg of pHXBCAT Bgl and 5 µg each of pSVIII-LAV or pSVIII-ELI
with or without 10 µg of pSVE7(427,TC). pSVIII-ELI encodes the Env of
the HIV-1 ELI strain. Cell-free viruses containing 105 cpm
of RT activity from each transfection were assayed for Env-mediated
viral infectivity. (B) Interference with viral infectivity mediated by
the Env proteins derived from primary isolates. 293 cells were
cotransfected with 7.5 µg of pHXBCAT Bgl and 5 µg each of
pSVIII-env expression plasmids that encoded Env proteins
derived from primary isolates as indicated with or without 10 µg of
pSVE7(427,TC). Viruses containing 105 cpm of RT activity
from each viral supernatant were used to challenge P4-R5 MAGI indicator
cells, and CAT activity was assayed.
|
|
Establishment and characterization of env-stably
transfected HeLa-CD4-LTR-
-gal clones.
To compare interference
by TC and 427,TC Env mutants in env CD4+ cells,
env-stably transfected HeLa-CD4-LTR-
-gal clones that harbored silent copies of the control
KS, wt, or mutant
pSVE7-puro env gene were generated. Approximately one copy
of the control
KS env gene and two to four copies of the
wt or mutant env gene were integrated into host chromosomal
DNA, as shown by Southern hybridization by using a
32P-labeled 2.7-kb XhoI fragment that contained
the entire env region linked to HIV-1 LTR derived from
pSVE7(
KS)-puro (Fig. 1B) as a probe (data not shown). The
selected env transfectants were transfected with or without
pIIIextat, followed by Western blotting with mouse
monoclonal antibodies (MAbs) Chessie 13 and Chessie 8 to detect Env
expression. These two hybridoma map to amino acid residues 252 to 273 and 727 to 732 of the Env of HIV-1LAI, respectively (1). Tat induction in the wt env transfectant
produced gp160, gp120, and gp41 (Fig. 5A,
lane 4). A truncated gp160 precursor, designated gp140, and gp120 were
detected in the TC transfectant upon Tat induction (Fig. 5A, lane 6). A
truncated gp160 precursor was also detected in the 427,TC transfectant
when Tat was expressed (Fig. 5A, lane 8), although the level of Env
produced by the 427,TC transfectant was less than those produced by the
wt and TC transfectants. No Env proteins could be detected in these
env transfectants in the absence of Tat induction (Fig. 5A,
odd-numbered lanes). Because the
KS transfectant harbored a
defective env gene construct, this transfectant was then
used as a negative control for later interference studies.

View larger version (75K):
[in this window]
[in a new window]
|
FIG. 5.
Characterization of env stable transfectants.
(A) Tat-dependent HIV-1 env gene expression in stable
env transfectants. The four env transfectants
were transfected with or without 5 µg of pIIIextat. Equal
amount of cell lysates from each transfection were subjected to an
SDS-7.5% PAGE, followed by Western blotting by using MAbs Chessie 8 and Chessie 13. m.w., molecular size. (B) Analysis of Tat-induced
Env expression in env transfectants by indirect
immunofluorescence microscopy. The four env transfectants as
indicated were transfected with pIIIextat. Three days after
transfection, cells were processed for immunofluorescence analysis as
described in Materials and Methods. Cells were analyzed under a
differential interference contrast microscope (panels a, c, e, and g)
or fluorescence microscope (panels b, d, f, and h), both at a
magnification of 200×.
|
|
To determine whether mutant Env expression in these
env
transfectants might cause cytopathic effects and syncytium
formation,
the four
env transfectants were transfected
with pIIIex
tat. Three
days after transfection, cells
were fixed, permeabilized, and
incubated with MAbs Chessie 13 and
Chessie 8, followed by incubation
with FITC-conjugated anti-mouse IgG.
As shown in Fig.
5B, neither
cytopathic effects nor immunofluorescence
signals were observed
in the control

KS transfectant (panels a and
b). Tat expression
in the wt
env transfectant resulted in
Env expression, as shown
by the perinuclear localization of
immunofluorescence signals
(panel d). It was also noted that expression
of the wt Env caused
cell-to-cell membrane fusion (panel d) and an
extensive cytopathic
effect (panel c). An endogenous TC mutant
env gene was also induced
to express upon Tat expression
(panel f), which was accompanied
by extensive cytopathic effects (panel
e). Nevertheless, syncytia
smaller than those found in the wt
transfectant were observed
in the TC transfectant. Unlike wt and TC
transfectants, induced
expression of the 427,TC mutant Env did not show
syncytia or cell-to-cell
fusion, since immunofluorescence signals were
found to be associated
with individual intact cells (panel
h).
Interference with exogenous wt Env-mediated cytopathic effects in
mutant env HeLa-CD4-LTR-
-gal transfectants.
To
examine whether expression of endogenous TC or 427,TC mutant Env could
interfere with wt Env-mediated cytopathic effects, the four
env transfectants were cotransfected with
pIIIextat and wt pSVE7-puro. Cotransfection
of pIIIextat with an exogenous wt env plasmid in
the control
KS and wt env transfectants resulted in
extensive cytopathic effects, including floating and dying cells, cell
lysis, and syncytium formation (Fig. 6A,
panels a and b, respectively). In any of the 10 fields microscopically examined, less than 10% of cells in these two cultures attached to the
petri dishes. Due to extensive cytopathic effects, precise scoring for
syncytia in these two transfectants was not possible. In contrast,
induced expression of endogenous TC or 427,TC mutant proteins
strikingly inhibited the cytopathic effect caused by the exogenous wt
Env expression (Fig. 6A, panels c and d, respectively). In any of the
10 fields examined, more than 90% of cells in these two cultures
remained intact, and no syncytia were visible. When the four
env transfectants were transfected with a cytomegalovirus promoter-driven LAV env expression plasmid
pCDNA3env(LAV), which did not encode a functional Tat
protein, 950, 980, 1,050, and 940 syncytia were observed in the control
KS, wt, TC, and 427,TC transfectants, respectively. Taken together,
these observations indicate that the lack of significant cytopathic
effects and syncytia in mutant transfectants is attributable to the
specific interference by the induced expression of the cytoplasmic
domain truncation mutants.

View larger version (86K):
[in this window]
[in a new window]
|
FIG. 6.
Interference with wt Env-mediated viral transmission in
mutant env transfectants. (A) Inhibition with exogenous
Env-mediated cytopathicity. The four env transfectants as
indicated were cotransfected with 10 µg of wt pSVE7-puro
and 5 µg of pIIIextat. Three days posttransfection
cultures were taken for photographs under a differential interference
contrast microscope with a magnification of ×200. This experiment was
performed three times, with similar results. Ten fields of each
transfected culture were observed, all with similar results. A
representative micrograph from each transfectant is shown. (B)
Interference with homologous HXB2-mediated cell-to-cell-mediated
transmission. The four env transfectants grown in
60-mm-diameter petri dishes with grids were cocultured with
HXB2-transfected SupT1 cells. Three days after transfection, cultures
were scored for syncytium formation. The degree of syncytium formation
in the control KS was arbitrarily set at 100%. The relative
syncytium formation observed in the wt and mutant transfectants was
expressed as the percentage of the numbers of syncytia observed
relative to that found in the control KS transfectant. The results
from four individual experiments were averaged, and means and standard
deviations were calculated. (C) Interference with heterologous
NL4-3-mediated virus-to-cell transmission. The env
transfectants as indicated were infected with the NL4-3 virus, and 3 days after infection, syncytia were scored. The diagram represents the
degree of syncytium formation obtained in four independent experiments
(means ± standard deviations).
|
|
Interference with viral infection mediated by T-tropic viruses in
mutant env transfectants.
To quantitate interference
with viral transmission by Env mutants, the four env
transfectants were cocultured with HXB2-transfected SupT1 cells and
scored for syncytium formation. The number of syncytia in the TC and
427,TC transfectants was reduced to 37.2 and 31.5%, respectively, of
that found in the control
KS transfectant (Fig. 6B). Coculture of
the wt transfectant showed a higher degree of syncytium formation than
did the control
KS coculture (Fig. 6B), indicating that a higher
level of Env expression in the wt transfectant results in higher levels
of syncytia than those found in the control
KS transfectant. To
assess whether expression of endogenous HXB2-derived mutant proteins
interfered with viral infection caused by a heterologous T-tropic HIV-1
virus, env transfectants were infected with the NL4-3 virus,
and infected cultures were scored for syncytium formation. Syncytium
formation in TC and 427,TC transfectants was reduced to 13.2 and 7.8%,
respectively, of that found in the control
KS transfectant (Fig.
6C).
Delayed replication and spread of T-tropic viruses in 427,TC mutant
env-transfected CEM-SS cells.
To further examine
dominant interference by Env mutants, interference with viral
replication in human CD4+ T cells was investigated. CEM-SS,
a human T4 lymphoblastoid cell line, was transfected with the control
KS, TC, or 427,TC pSVE7-puro by electroporation and then
grown in media containing puromycin for 3 weeks. The resultant cell
populations were challenged with the HXB2 virus. Infection of CEM-SS
transfected with the control
KS env construct showed a
peak of RT production 15 days after infection (Fig.
7A). Replication of the HXB2 virus in TC
env-transfected CEM-SS showed kinetics similar to those
observed in the
KS env-transfected cells. In contrast,
infection of 427,TC env-transfected cells showed a delay in
viral replication with a peak of RT production occurring 22 days after
infection. When the env-transfected CEM-SS cells were
challenged with the NL4-3 virus, there was also a delay in viral
replication in 427,TC env-transfected cells compared to
viral replication in
KS env-transfected CEM-SS cells
(Fig. 7B). Also, the delay in NL4-3 replication in TC
env-transfected CEM-SS was less significant than that
observed in 427,TC env-transfected cells (Fig. 7B).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 7.
Effect of Env truncation mutants on T-tropic viral
replication in human CD4+ T cells. (A) Interference with
viral replication and spread caused by the homologous HXB2 virus. The
puromycin-selected CEM-SS cells transfected with various
pSVE7-puro env constructs as indicated were infected with
the HXB2 virus, and RT activity was monitored after infection. (B)
Interference with NL4-3 virus-mediated viral replication and spread.
CEM-SS cells transfected with env constructs as indicated in
panel A were infected with the NL4-3 virus, and RT activity was
monitored after infection. In panels A and B, similar results were
obtained from at least three infection analyses. A representative
result from each is shown. (C) Characterization of
env-transfected CEM-SS cells. Left panel shows the presence
of the env genes in transfected CEM-SS cells. Lysates
obtained from equal volumes of env-transfected CEM-SS cells
were analyzed by PCR by using env and -globin primers as
described in Materials and Methods. PCR products of each transfectant
were mixed and resolved by 3% Nusieve agarose electrophoresis. The
right panel shows Tat-induced Env expression in
env-transfected CEM-SS cells. We transfected 107
CEM-SS cells harboring the env genes as indicated with 10 µg of pIIIextat. Three days after transfection, cell
lysates were prepared and analyzed by Western blotting by using Chessie
13 and 902 MAbs. To indicate the migration position of the wt Env
precursor, HIV-1-infected CEM-SS cell lysate was also analyzed in
parallel (lane 4).
|
|
To determine whether these
env genes were integrated into
host chromosomal DNA, cell lysates obtained from the

KS, TC, and
427,TC
env-transfected CEM-SS were analyzed by PCR by using
env primers to detect the presence of
env
sequence from nucleotides
positioned 7795 to 7936. PCR designed to
amplify the human

-globin
gene from nucleotides 14 to 123, relative
to the translation initiation
site, was also performed. The
env PCR signals were detected in
CEM-SS cells transfected
with either the control

KS, TC, or 427,TC
env construct
(Fig.
7C, left panel). To determine whether mutant
Env was expressed
upon Tat induction, the control

KS, TC, or
427,TC
env-transfected CEM-SS cells were transfected with
pIIIex
tat by the DEAE-dextran method. Cell lysates were
analyzed by Western
blotting with MAbs 902 and Chessie 13. MAb 902 is
specific for
the gp120 V3 region of the LAV and IIIB strains of HIV-1.
Truncated
Env precursor was produced in TC and 427,TC
env-transfected CEM-SS
cells upon Tat induction (Fig.
7C,
right panel, lanes 2 and 3,
respectively).
Interference with replication of M-tropic isolates in 427,TC
env-transfected PM1 cells.
To determine whether 427,TC
conferred dominant interference with infection caused by M-tropic
viruses, a CD4+ T-cell line PM1 (32), a Hut 78 derivative that expresses both CXCR4 and CCR5 coreceptors, was
transfected with the control
KS, TC, or 427,TC env
construct. The puromycin-selected cells were then infected with ConB
virus (43), which was produced from COS-1 cells transfected
with the proviral DNA clone. The ConB virus, containing the consensus
V3 sequences of HIV-1 subtype B in the backbone of the molecular clone
HXB2RU3 (42), utilizes CCR5, but not CXCR4, as an entry
coreceptor (43). PM1 cells harboring the 427,TC
env gene showed a lower level of viral production than that
observed in cells harboring the control
KS or TC env gene
(Fig. 8A). Also, the
env-transfected PM1 cells were infected with another
M-tropic ADA-GG virus (43a). ADA-GG is an HXB2RU3-derived primary virus in which the sequence between the two BglI
sites that encode residues 273 to 476 of gp120 was replaced by the
homologous sequence from the M-tropic primary isolate ADA
(44). Viral production was inhibited in 427,TC
env-transfected PM1 cells as opposed to viral production
observed in the control
KS or TC env-transfected cells
(Fig. 8B).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 8.
Interference with M-tropic viral replication in mutant
env-transfected PM1 cells. PM1 cells were transfected with
the pSVE7-puro env constructs as indicated by
electroporation. The puromycin-selected transfected cells were infected
with the ConB (A) or ADA-GG (B) virus, and RT activity was monitored
after infection. Each experiment was performed three times, with
similar results. A representative result for each is shown.
|
|
 |
DISCUSSION |
In the present study, the feasibility of utilizing the gp41
cytoplasmic domain as a target for the design of a genetic anti-HIV approach was investigated. An HXB2 env-isogenic TC mutant
lacking the whole cytoplasmic domain and the last two amino acids in
the TM region as well as a series of mutants with deletions from the C
terminus of the cytoplasmic domain dominantly interfere with wt
Env-mediated viral infectivity (Fig. 2B and 3B). It was reported that
deletions in the cytoplasmic domain affect Env stability in a cell
type-dependent manner (24). Nevertheless, the incorporation of mutant Env proteins into virions appears to be normal
(24). In contrast, other studies showed that truncations in
the cytoplasmic domain, such as mutants TM775 and TM795, may impair Env
incorporation into virions (16, 46). Viruses carrying TC,
TM844, and TM813 mutations are severely impaired in infectivity, though
assembly and release and Env incorporation of these viruses are not
significantly altered (9, 46). The mechanism for the
dominant interference by TC, TM844, and TM813 mutants may be via the
ability of these mutants to trans-dominantly inhibit wt
Env-mediated viral entry.
Unlike the CD4 binding-defective 41.2 double mutant (5), the
syncytium-defective 427,TC mutant (Fig. 1C and 5B) dominantly interferes with viral transmission as effectively as the TC mutant (Fig. 2B and 6) and also confers interference with heterologous T-tropic Env-mediated viral infectivity (Fig. 4A). These observations indicate that interference by the TC mutant does not require a functional CD4-binding domain. In addition, the 427,TC mutant also
dominantly interferes with syncytium formation and viral infectivity
mediated by the Env proteins derived from two primary isolates 92BR and
92US, although less interference was observed in the syncytium assay
than in the one-round viral replication assay (compare Table 1 to Fig.
4B). In the syncytium formation assay, cell-to-cell transmission is
predominantly encountered, whereas in the env
trans-complementation assay virus-to-cell transmission is
encountered. The differential interference in these two assays may be
attributable to the possibility that cell-cell and virus-cell fusion
have different requirements for the Env structures and/or for the
numbers of successful Env-CD4 interactions (6, 26). In
env trans-complementation assays (Fig. 2B, 3B, and 4),
recombinant virus produced from cotransfection of an
env-defective reporter provirus with pSVE7(
KS) was used
as a negative control. Also, pSVE7(
KS) was added into transfection
mixtures to keep the total amount of env plasmids in all
transfections the same. Therefore, the interference in viral
infectivity observed in wt and mutant Env coexpression is attributed to
the specific effect of the mutant Env, not to other nonspecific effects
such as promoter competition.
For interference with exogenous wt Env-mediated cytopathic effects in
HeLa-CD4-LTR-
-gal transfectants (Fig. 6A), two clones each of the TC
and 427,TC transfectants were initially found to effectively inhibit
exogenous wt Env-mediated cytopathicity. A clone selected at random
from each mutant was further assessed for interference. Although the
427,TC transfectant produces a lower level of Env upon Tat induction
than other transfectants (Fig. 5A), this double mutant exhibits an
interfering effect as effective as the TC mutant in
HeLa-CD4-LTR-
-gal transfectant analysis (Fig. 6). The reduced level
of Env production in the 427,TC transfectant is not due to the reduced
transfection efficiency of this particular clone as indicated by the
similarity of the luciferase activity levels detected in all
env transfectants when these transfectants were transfected
with an env-defective, replication-incompetent pNL4-3-luc-R
E
provirus (12)
(data not shown). The decreased Env production appears to be a general
feature of transfectants harboring the 427,TC mutant env,
since three other 427,TC transfectants also show the same phenotype
(data not shown). Interference by TC and 427,TC transfectants is
apparently not due to decreased cell surface CD4 expression, since all
of the env transfectants show similar cell surface CD4
levels (data not shown). Because both TC and 427,TC, but not the wt
transfectant, exhibit interference upon viral infection (Fig. 6), these
studies indicate that the interference examined in the mutant
transfectants is specific for a cytoplasmic domain truncation.
Since the dominant mutant env genes are not yet induced to
express in the HeLa-CD4-LTR-
-gal stable clones or in transfected human CD4+ T cells during the first round of viral
infection, no interference in viral entry by Env mutants could be
anticipated in the initial infection. In fact, when the four
HeLa-CD4-LTR-
-gal env transfectants were challenged with
a cat-encoding, env-defective virus pseudotyped with the wt Env, similar levels of CAT activity were observed (data not
shown). This observation is consistent with the finding that these
env transfectants display similar levels of CD4 on the cell
surface. Moreover, when the control
KS, TC, and 427,TC env-transfected CEM-SS were assayed for one-round viral
replication, they also showed comparable levels of CAT activity (data
not shown). These studies indicate that these mutant CD4+
env transfectants support single-cycle viral replication.
The observations that the virus replicates efficiently in CEM-SS cells transfected with the TC mutant env gene and ultimately
replicates productively in CEM-SS cells transfected with the 427,TC
mutant env gene (Fig. 7A and 7B) also support this notion.
The differential syncytium formation and viral replication among
env transfectants (Fig. 6B and C and Fig. 7 and 8) may
reflect an overall effect by Env mutants on subsequent viral
infections. Tat produced by infected cells can be secreted and
endocytosed by surrounding uninfected cells (20).
Tat-induced expression of mutant Env proteins in initially infected or
surrounding cells thus activates a defensive mechanism by forming a wt
and mutant dysfunctional hetero-oligomer upon wt Env coexpression,
which limits viral spread. Buchschacher et al. demonstrated that the
41.2 mutant-transfected HeLa-CD4 clone interferes with syncytium
formation within 4 days following HIV infection or transfection with an
HIV provirus (4). Their results show the feasibility of
utilizing the HeLa-CD4 stable clone approach to address interference
with viral spread by Env mutants. Moreover, the kinetic analysis of
viral replication in human CD4+ T cells (Fig. 7 and 8)
demonstrates the specific interference of the 427,TC mutant in multiple
viral replication cycles in targeted CD4+ T cells. Since
env-transfected CEM-SS and PM1 cells were selected for the
puromycin resistance gene inserted in the env expression cassettes (Fig. 7 and 8), the selected cell populations represent a
pool of env clones. Therefore, the interference observed in CD4+ T cells reflects the combinatory effects of individual
clones, which avoids the problem of clonal heterogeneity due to
differential Env expression in different clones.
The lack of effective interference by TC mutant in human
CD4+ T cells (Fig. 7 and 8) cannot be attributed to the
lack of TC env integration into host DNA or to the lack of
TC expression upon Tat induction (Fig. 7C). An env-defective
virus pseudotyped with certain cytoplasmic domain deletion mutants
produced by COS-1 cells and then used to infect Jurkat cells may
replicate differentially from virus whose replication is examined by
using a similar transient complementation assay in transfected Jurkat
cell cultures (24). Also, in Jurkat cells, some of the
deletion mutants have a syncytium-forming ability equal to or greater
than that of the wt Env. However, these deletion mutants may have lower
syncytium-forming ability than the wt Env when they are produced in
COS-1 (24). It is likely that in HeLa-CD4-LTR-
-gal
transfectant, the wt-mutant TC hetero-oligomers are restricted to their
mediation of viral transmission, resulting in interference with viral
transmission. In human CD4+ T cells, such hetero-oligomers
may still be able to mediate viral replication, resulting in less
interference. The more pronounced interference effect by the 427,TC
mutant compared to that of the TC mutant in human CD4+ T
cells may be attributed to the absolute defective syncytium-forming nature of the 427,TC mutant.
Viral replication in CEM-SS or PM1 cells harboring the 427,TC mutant
env gene is retarded but not completely blocked (Fig. 7 and
8). Early in infection, Tat-induced mutant 427,TC expression appears to
be sufficient to neutralize the wt Env synthesized de novo by forming a
dysfunctional hetero-oligomer. As the infection process continues de
novo wt Env synthesis may accumulate to a threshold level. Beyond this
level, the wt Env synthesized can no longer be neutralized by the
427,TC Env, thus resulting in a burst of virus production.
Alternatively, upon infection of a cell that also expresses the 427,TC
mutant, a fraction of wt homo-oligomer is present in the total Env
population. The presence of a residual fraction of virus assembled with
the wt homo-oligomer may ultimately result in overt productive infection.
The use of env transfectants to address Env-targeted
dominant interference differs from those transient coexpression
analyses. The transient coexpression analysis examines the ability of
wt and mutant coexpressed proteins to mediate viral entry into
CD4+ cells. In env transfectant analyses, as
presented here, the mutant env genes are first directed to
the CD4+ cells, and only upon viral infection is the
expression of these mutant genes induced. This approach directly
assesses the antiviral effect of trans-dominant
env mutant genes in targeted CD4+ cells. In the
present study, we demonstrate that the HXB2 env-derived 427,TC double mutant exhibits dominant interference with the Env functions of T-tropic and M-tropic viruses. Moreover, human
CD4+ T cells harboring the 427,TC env gene slow
T-tropic and M-tropic viral replication and spread. Thus, this design,
by itself or in combination with other approaches, may have a role in
the development of genetic anti-HIV strategies.
 |
ACKNOWLEDGMENTS |
The following cells, antibodies, and plasmids were obtained from
the AIDS Research and Reference Reagent Program, National Institute of
Allergy and Infectious Diseases, National Institutes of Health:
HeLa-CD4-LTR-
-gal (from Michael Emerman), SupT1 (from James Hoxie),
CEM-SS (from Peter L. Nara), PM1 (from Marvin Reitz, Jr.), hybridoma
Chessie 8 and Chessie 13 (from George K. Lewis) and 902 (from Bruce
Chesebro), P4-R5 MAGI (from Nathaniel Landau), goat anti-gp120 (from
Michael Phelan), pNL4-3 (from Malcom Martin), and pSVIII-92RW020-5,
pSVIII-92BR20.4, and pSVIII-92US715.6 (from Beatrice Hahn).
pNL4-3-luc-R
E
was a gift from Nathaniel
Landau (New York University Medical School, New York, N.Y.). pSVE7-ELI
was obtained from Ernest F. Terwilliger (Harvard Medical School,
Boston, Mass.). The ConB and ADA-GG proviral clones and HXB2R3-derived
proviruses TM844, TM812, TM795, TM775, TM752, and TM709 were gifts from
Ton-Hou Lee (Harvard School of Public Health, Boston, Mass.).
This work was supported by grants from the National Science Council
(NSC 86-2314-B-001-017, NSC 87-2314-B-001-035, and NSC 88-2314-B-001-027) and from the Institute of Biomedical Sciences at
Academia Sinica, Taipei, Taiwan, Republic of China. We are indebted to
Huey-Jong Hao for technical assistance with DNA cloning and sequencing.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Infectious Diseases, Institute of Biomedical Sciences, Academia Sinica, 128, Section 2, Yen-Chiu-Yuan Rd., Taipei, Taiwan, Republic of China.
Phone: 886-2-2652-3933. Fax: 886-2-2785-8847. E-mail:
schen{at}ibms.sinica.edu.tw.
Present address: Division of Cardiovascular Research, Institute of
Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China.
 |
REFERENCES |
| 1.
|
Abacioglu, Y. H.,
T. R. Fouts,
J. D. Laman,
E. Claasen,
S. H. Pincus,
J. P. Moore,
C. A. Roby,
R. Kamin-Lewis, and G. K. Lewis.
1994.
Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies.
AIDS Res. Hum. Retroviruses
10:371-381[Medline].
|
| 2.
|
Adachi, A.,
H. E. Gendelman,
S. Koenig,
T. Folks,
R. Willey,
A. Rabson, and M. A. Martin.
1986.
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
J. Virol.
59:284-291[Abstract/Free Full Text].
|
| 3.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl.
1995.
Current protocols in molecular biology, vol. 2.
John Wiley & Sons, New York, N.Y.
|
| 4.
|
Buchschacher, G. L., Jr.,
E. O. Freed, and A. T. Panganiban.
1992.
Cells induced to express a human immunodeficiency virus type 1 envelope gene mutant inhibit the spread of wild-type virus.
Hum. Gene Ther.
3:391-397[Medline].
|
| 5.
|
Buchschacher, G. L., Jr.,
E. O. Freed, and A. T. Panganiban.
1995.
Effects of second-site mutation on dominant interference by a human immunodeficiency virus type 1 envelope glycoprotein mutant.
J. Virol.
69:1344-1348[Abstract].
|
| 6.
|
Cao, J.,
L. Bergeron,
E. Helseth,
M. Thali,
H. Repke, and J. Sodroski.
1993.
Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein.
J. Virol.
67:2747-2755[Abstract/Free Full Text].
|
| 7.
|
Charneau, P.,
G. Mirambeau,
P. Roux,
S. Paulous,
H. Buc, and P. Clavel.
1994.
HIV-1 reverse transcription: a termination step of the center of the genome.
J. Biol. Chem.
241:651-662[Abstract/Free Full Text].
|
| 8.
|
Chen, S. S.-L.
1994.
Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41.
J. Virol.
68:2002-2010[Abstract/Free Full Text].
|
| 9.
|
Chen, S. S.-L.,
A. A. Ferrante, and E. F. Terwilliger.
1996.
Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity.
Virology
226:260-268[Medline].
|
| 10.
|
Chen, S. S.-L.,
C.-N. Lee,
W.-R. Lee,
K. McIntosh, and T.-H. Lee.
1993.
Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein.
J. Virol.
67:3615-3619[Abstract/Free Full Text].
|
| 11.
|
Chen, S. S.-L.,
S.-F. Lee,
H.-J. Hao, and C.-K. Chuang.
1998.
Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity.
J. Virol.
72:4765-4774[Abstract/Free Full Text].
|
| 12.
|
Conor, R. L.,
B. K. Chen, and N. R. Landau.
1995.
Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.
Virology
206:935-944[Medline].
|
| 13.
|
Cordonnier, A.,
L. Montanier, and M. Emerman.
1989.
Single amino-acid changes in HIV envelope affect viral tropism and receptor binding.
Nature (London)
340:571-574[Medline].
|
| 14.
|
Cosson, P.
1996.
Direct interaction between the envelope and matrix proteins of HIV-1.
EMBO J.
15:5783-5788[Medline].
|
| 15.
|
Dorfman, T.,
F. Mannano,
W. A. Haseltine, and H. G. Göttlinger.
1994.
Role of matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.
J. Virol.
68:1689-1696[Abstract/Free Full Text].
|
| 16.
|
Dubay, J. W.,
S. Robers,
B. H. Haln, and E. Hunter.
1992.
Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity.
J. Virol.
66:6016-6025.
|
| 17.
|
Earl, P. L.,
S. Koenig, and B. Moss.
1991.
Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.
J. Virol.
65:31-41[Abstract/Free Full Text].
|
| 18.
|
Fisher, A. G.,
E. Collalti,
L. Ratner,
R. C. Gallo, and F. Wong-Staal.
1985.
A molecular clone of HTLV-III with biological activity.
Nature (London)
316:262-265[Medline].
|
| 19.
|
Fisher, A. G.,
L. Ratner,
H. Mitsuya,
L. M. Marselle,
M. E. Harper,
S. Broders,
R. C. Gallo, and F. Wong-Staal.
1986.
Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects.
Science
233:655-659[Abstract/Free Full Text].
|
| 20.
|
Frankel, A. D., and C. D. Pabo.
1988.
Cellular uptake of the tat protein from human immunodeficiency virus.
Cell
55:1189-1193[Medline].
|
| 21.
|
Freed, E. O.,
E. L. Delwart,
G. L. Buchschacher, Jr., and A. T. Panganiban.
1992.
A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity.
Proc. Natl. Acad. Sci. USA
89:70-74[Abstract/Free Full Text].
|
| 22.
|
Freed, E. O., and M. A. Martin.
1996.
Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
J. Virol.
70:341-351[Abstract].
|
| 23.
|
Freed, E. O., and M. A. Martin.
1995.
Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.
J. Virol.
69:1984-1989[Abstract].
|
| 24.
|
Gabuzda, D. H.,
A. Lever,
E. Terwilliger, and J. Sodroski.
1992.
Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.
J. Virol.
66:3306-3315[Abstract/Free Full Text].
|
| 25.
|
Gao, F.,
S. G. Morrison,
D. L. Robertson,
C. L. Thornton,
S. Craig,
G. Karlsson,
J. Sodroski,
M. Morgado,
B. Galvao-Castro,
H. von Briesen,
S. Beddows,
J. Weber,
P. M. Sharp,
G. M. Shaw,
B. H. Hahn, and the WHO and NIAID Networks for HIV Isolation and Characterization.
1996.
Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G.
J. Virol.
70:1651-1667[Abstract].
|
| 26.
|
Helseth, E.,
M. Kowalski,
D. Gabuzda,
U. Olshevsky,
W. Haseltine, and J. Sodroski.
1990.
Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants.
J. Virol.
64:2416-2420[Abstract/Free Full Text].
|
| 27.
|
Helseth, E.,
U. Olshevsky,
D. Gabuzda,
B. Ardman,
W. Haseltine, and J. Sodroski.
1990.
Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion.
J. Virol.
64:6314-6318[Abstract/Free Full Text].
|
| 28.
|
Kowalski, M.,
J. Potz,
L. Basiripour,
T. Dorfman,
W. C. Goh,
E. Terwilliger,
A. Dayton,
C. Rosen,
W. Haseltine, and J. Sodroski.
1987.
Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.
Science
237:1351-1355[Abstract/Free Full Text].
|
| 29.
|
Kunkel, T. A.
1985.
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Proc. Natl. Acad. Sci. USA
82:488-492[Abstract/Free Full Text].
|
| 30.
|
Lee, S.-J.,
W. Hu,
A. G. Fisher,
D. J. Looney,
V. F. Kao,
H. Mitsuya,
L. Ratner, and F. Wong-Staal.
1989.
Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity.
AIDS Res. Hum. Retroviruses
5:441-449[Medline].
|
| 31.
|
Lodge, R.,
J.-P. Lalonde,
G. Lemay, and E. A. Cohen.
1997.
The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells.
EMBO J.
16:695-705[Medline].
|
| 32.
|
Lusso, P.,
F. Cocchi,
C. Balotta,
P. D. Markham,
A. Louie,
P. Farci,
R. Pai,
R. C. Gallo, and M. S. Reitz, Jr.
1995.
Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.
J. Virol.
69:3712-3720[Abstract].
|
| 33.
|
Mannano, F.,
E. Kondo,
J. Sodroski,
A. Bukovsky, and H. G. Göttlinger.
1995.
Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.
J. Virol.
69:3824-3830[Abstract].
|
| 34.
|
Owens, R. J.,
C. Burke, and J. K. Rose.
1994.
Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity.
J. Virol.
68:570-574[Abstract/Free Full Text].
|
| 35.
|
Peden, K.,
M. Emerman, and L. Montagnier.
1991.
Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI.
Virology
185:661-672[Medline].
|
| 36.
|
Ratner, L.,
M. Fisher,
L. L. Jagodzinski,
H. Mitsuya,
R.-S. Liou,
R. C. Gallo, and F. Wong-Staal.
1987.
Complete nucleotide sequences of functional clones of the AIDS virus.
AIDS Res. Hum. Retroviruses
3:57-69[Medline].
|
| 37.
|
Rowell, J. F.,
P. E. Stanhope, and R. F. Siliciano.
1995.
Endocytosis of endogenously synthesized HIV-1 envelope protein: mechanism and role in processing for association with class II MHC.
J. Immunol.
155:473-488[Abstract].
|
| 38.
|
Srinivas, S. K.,
R. V. Srinivas,
G. M. Anantharamaiah,
R. W. Compans, and J. P. Segrest.
1993.
Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins.
J. Biol. Chem.
268:22895-22899[Abstract/Free Full Text].
|
| 39.
|
Steffy, K. R., and F. Wong-Staal.
1993.
Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant.
J. Virol.
67:1854-1859[Abstract/Free Full Text].
|
| 40.
|
Tencza, S. B.,
M. A. Miller,
K. Islam,
T. A. Mietzner, and R. C. Montelaro.
1995.
Effect of amino acid substitutions on calmodulin binding and cytolytic properties of the LLP-1 peptide segment of human immunodeficiency virus type 1 transmembrane protein.
J. Virol.
69:5199-5202[Abstract].
|
| 41.
|
Terwilliger, E.,
J. G. Sodroski,
C. A. Rosen, and W. A. Haseltine.
1986.
Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity.
J. Virol.
60:754-760[Abstract/Free Full Text].
|
| 42.
|
Trujillo, J. R.,
W. K. Wang,
T.-H. Lee, and M. Essex.
1996.
Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1.
Virology
217:613-617[Medline].
|
| 43.
|
Wang, W.-K.,
T. Duder,
Y.-J. Zhao,
H. G. Brumblay,
M. Essex, and T.-H. Lee.
1998.
CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV-1 type 1 gp120.
Proc. Natl. Acad. Sci. USA
95:5740-5745[Abstract/Free Full Text].
|
| 43a.
| Wang, W.-K., and T.-H. Lee.
Unpublished results.
|
| 44.
|
Westervelt, P.,
H. E. Gendelman, and L. Ratner.
1991.
Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes.
Proc. Natl. Acad. Sci. USA
88:3097-3101[Abstract/Free Full Text].
|
| 45.
|
Yu, X.,
X. Yuan,
Z. Matsuda,
T.-H. Lee, and M. Essex.
1992.
The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.
J. Virol.
66:4966-4971[Abstract/Free Full Text].
|
| 46.
|
Yu, X.,
X. Yuan,
M. F. McLane,
T.-H. Lee, and M. Essex.
1993.
Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of the Env proteins into mature virions.
J. Virol.
67:213-221[Abstract/Free Full Text].
|
Journal of Virology, October 1999, p. 8290-8302, Vol. 73, No. 10
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chen, S. S.-L., Yang, P., Ke, P.-Y., Li, H.-F., Chan, W.-E., Chang, D.-K., Chuang, C.-K., Tsai, Y., Huang, S.-C.
(2009). Identification of the LWYIK Motif Located in the Human Immunodeficiency Virus Type 1 Transmembrane gp41 Protein as a Distinct Determinant for Viral Infection. J. Virol.
83: 870-883
[Abstract]
[Full Text]
-
Gordon-Alonso, M., Yanez-Mo, M., Barreiro, O., Alvarez, S., Munoz-Fernandez, M. A., Valenzuela-Fernandez, A., Sanchez-Madrid, F.
(2006). Tetraspanins CD9 and CD81 Modulate HIV-1-Induced Membrane Fusion. J. Immunol.
177: 5129-5137
[Abstract]
[Full Text]
-
Ou, W., Silver, J.
(2005). Inhibition of Murine Leukemia Virus Envelope Protein (Env) Processing by Intracellular Expression of the Env N-Terminal Heptad Repeat Region. J. Virol.
79: 4782-4792
[Abstract]
[Full Text]
-
Chan, W.-E., Wang, Y.-L., Lin, H.-H., Chen, S. S.-L.
(2004). Effect of Extension of the Cytoplasmic Domain of Human Immunodeficiency Type 1 Virus Transmembrane Protein gp41 on Virus Replication. J. Virol.
78: 5157-5169
[Abstract]
[Full Text]
-
Lee, S.-F., Ko, C.-Y., Wang, C.-T., Chen, S. S.-L.
(2002). Effect of Point Mutations in the N Terminus of the Lentivirus Lytic Peptide-1 Sequence of Human Immunodeficiency Virus Type 1 Transmembrane Protein gp41 on Env Stability. J. Biol. Chem.
277: 15363-15375
[Abstract]
[Full Text]
-
Chen, S. S.-L., Lee, S.-F., Wang, C.-T.
(2001). Cellular Membrane-Binding Ability of the C-Terminal Cytoplasmic Domain of Human Immunodeficiency Virus Type 1 Envelope Transmembrane Protein gp41. J. Virol.
75: 9925-9938
[Abstract]
[Full Text]
-
Lever, A M L
(2001). Gene therapy for HIV. Sex. Transm. Infect.
77: 93-96
[Full Text]
-
Lee, S.-F., Wang, C.-T., Liang, J. Y.-P., Hong, S.-L., Huang, C.-C., Chen, S. S.-L.
(2000). Multimerization Potential of the Cytoplasmic Domain of the Human Immunodeficiency Virus Type 1 Transmembrane Glycoprotein gp41. J. Biol. Chem.
275: 15809-15819
[Abstract]
[Full Text]